16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Gomez G, Saborido MD, Alejandra Bernardi M, Gershanik OS, Taravini IR, Ferrario JE. Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia. Neuroscience Letters. 666: 5-10. PMID 29241709 DOI: 10.1016/j.neulet.2017.12.024  0.72
2017 Sanz-Blasco S, Bordone MP, Damianich A, Gomez G, Bernardi MA, Isaja L, Taravini IR, Hanger DP, Avale ME, Gershanik OS, Ferrario JE. The Kinase Fyn As a Novel Intermediate in L-DOPA-Induced Dyskinesia in Parkinson's Disease. Molecular Neurobiology. PMID 28840468 DOI: 10.1007/s12035-017-0748-3  0.72
2016 Tubert C, Taravini IR, Flores-Barrera E, Sánchez GM, Prost MA, Avale ME, Tseng KY, Rela L, Murer MG. Decrease of a Current Mediated by Kv1.3 Channels Causes Striatal Cholinergic Interneuron Hyperexcitability in Experimental Parkinsonism. Cell Reports. PMID 27568555 DOI: 10.1016/j.celrep.2016.08.016  0.72
2016 Escande MV, Taravini IR, Zold CL, Belforte JE, Murer MG. Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 5686-98. PMID 27225760 DOI: 10.1523/JNEUROSCI.0492-15.2016  0.72
2015 Taravini IR, Larramendy C, Gomez G, Saborido MD, Spaans F, Fresno C, González GA, Fernández E, Murer MG, Gershanik OS. Contrasting gene expression patterns induced by levodopa and pramipexole treatments in the rat model of Parkinson's disease. Neuropharmacology. PMID 25963416 DOI: 10.1016/j.neuropharm.2015.04.018  0.72
2015 Braz BY, Galiñanes GL, Taravini IR, Belforte JE, Murer MG. Altered Corticostriatal Connectivity and Exploration/Exploitation Imbalance Emerge as Intermediate Phenotypes for a Neonatal Dopamine Dysfunction. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25872916 DOI: 10.1038/npp.2015.104  0.72
2015 Taravini IR, Larramendy C, Gomez G, Saborido MD, Spaans F, Fresno C, González GA, Fernández E, Murer MG, Gershanik OS. Contrasting gene expression patterns induced by levodopa and pramipexole treatments in the rat model of Parkinson's disease Neuropharmacology. DOI: 10.1016/j.neuropharm.2015.04.018  0.72
2014 Suárez LM, Solís O, Caramés JM, Taravini IR, Solís JM, Murer MG, Moratalla R. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. Biological Psychiatry. 75: 711-22. PMID 23769604 DOI: 10.1016/j.biopsych.2013.05.006  0.72
2011 Taravini IR, Chertoff M, Cafferata EG, Courty J, Murer MG, Pitossi FJ, Gershanik OS. Pleiotrophin over-expression provides trophic support to dopaminergic neurons in parkinsonian rats. Molecular Neurodegeneration. 6: 40. PMID 21649894 DOI: 10.1186/1750-1326-6-40  0.72
2011 Raineri M, Peskin V, Goitia B, Taravini IR, Giorgeri S, Urbano FJ, Bisagno V. Attenuated methamphetamine induced neurotoxicity by modafinil administration in mice. Synapse (New York, N.Y.). 65: 1087-98. PMID 21590747 DOI: 10.1002/syn.20943  0.72
2009 Galiñanes GL, Taravini IR, Murer MG. Dopamine-dependent periadolescent maturation of corticostriatal functional connectivity in mouse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 2496-509. PMID 19244524 DOI: 10.1523/JNEUROSCI.4421-08.2009  0.72
2008 Larramendy C, Taravini IR, Saborido MD, Ferrario JE, Murer MG, Gershanik OS. Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism. Behavioural Brain Research. 194: 44-51. PMID 18638507 DOI: 10.1016/j.bbr.2008.06.021  0.72
2007 Delfino M, Kalisch R, Czisch M, Larramendy C, Ricatti J, Taravini IR, Trenkwalder C, Murer MG, Auer DP, Gershanik OS. Mapping the effects of three dopamine agonists with different dyskinetogenic potential and receptor selectivity using pharmacological functional magnetic resonance imaging. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1911-21. PMID 17287822 DOI: 10.1038/sj.npp.1301329  0.72
2005 Taravini IR, Ferrario JE, Delbe J, Ginestet L, Debeir T, Courty J, Murer MG, Gershanik OS, Raisman-Vozari R. Immunodetection of heparin-binding growth associated molecule (pleiotrophin) in striatal interneurons. Brain Research. 1066: 196-200. PMID 16325783 DOI: 10.1016/j.brainres.2005.10.055  0.72
2004 Ferrario JE, Taravini IR, Mourlevat S, Stefano A, Delfino MA, Raisman-Vozari R, Murer MG, Ruberg M, Gershanik O. Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system. Journal of Neurochemistry. 90: 1348-58. PMID 15341519 DOI: 10.1111/j.1471-4159.2004.02595.x  0.72
2004 Delfino MA, Stefano AV, Ferrario JE, Taravini IR, Murer MG, Gershanik OS. Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias. Behavioural Brain Research. 152: 297-306. PMID 15196797 DOI: 10.1016/j.bbr.2003.10.009  0.72
Show low-probability matches.